Recent News

• 04.15.2025 - NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
• 03.20.2025 - NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
• 03.20.2025 - NeurAxis Fourth Quarter 2024 Earnings Conference Call
• 03.20.2025 - NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
• 03.12.2025 - NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
• 03.12.2025 - NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
• 02.17.2025 - Gil Aharon
• 01.21.2025 - UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
• 01.21.2025 - NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
• 01.21.2025 - NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Recent Filings

• 04.14.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.14.2025 - DEF 14A Other definitive proxy statements
• 04.04.2025 - PRE 14A Other preliminary proxy statements
• 04.04.2025 - ARS Annual Report to Security Holders
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.12.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.11.2025 - EFFECT Notice of Effectiveness
• 02.07.2025 - CORRESP Correspondence
• 02.05.2025 - S-3/A Registration statement under Securities Act of 1933